The company said the weight-loss drug will be available at the same self-pay price in either the single-dose vial format or ...
1don MSN
Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen
Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
Feb 23 (Reuters) - Eli Lilly said on Monday it received the U.S. Food and Drug Administration's approval to launch a four-dose KwikPen for its weight-loss drug Zepbound, delivering a full month of the ...
The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...
The FDA-approved Zepbound KwikPen delivers a full month of treatment in one device and will be available to self-pay patients through LillyDirect starting Feb. 23.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results